Polycystic Kidney Disease, Autosomal Dominant
2 clinical trials · Condition
◉ Watch Polycystic Kidney Disease, Autosomal Dominant
| Record | Firm | Date |
|---|---|---|
| A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease (NCT04536688) | Regulus Therapeutics Inc. | 2020-10-13 |
| Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) (NCT00428948) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2007-01-01 |
Track Polycystic Kidney Disease, Autosomal Dominant automatically
Every clearance here is in the API, with alerts when new ones post.